Zebra Capital Management LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 231 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
Zebra Capital Management LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$256
-25.6%
6,695
+10.8%
1.28%
+6.3%
Q4 2022$344
-99.8%
6,042
+14.9%
1.20%
+51.9%
Q3 2022$208,000
-31.4%
5,257
-23.6%
0.79%
-11.0%
Q2 2022$303,000
+21.2%
6,877
+9.7%
0.89%
+55.1%
Q1 2022$250,000
-8.1%
6,267
-7.3%
0.57%
+32.0%
Q4 2021$272,000
-27.7%
6,761
-26.9%
0.44%
-4.4%
Q3 2021$376,000
-11.5%
9,254
-1.0%
0.46%
-8.6%
Q2 2021$425,000
-1.6%
9,350
-9.7%
0.50%
+4.6%
Q1 2021$432,000
+104.7%
10,359
-23.3%
0.48%
+106.1%
Q3 2019$211,00013,5000.23%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$51,293,0007.24%
First Light Asset Management, LLC 2,050,273$93,103,0005.59%
TRAN CAPITAL MANAGEMENT, L.P. 1,350,870$61,343,0005.06%
SNYDER CAPITAL MANAGEMENT L P 3,176,404$144,241,0004.04%
DOHENY ASSET MANAGEMENT /CA 91,930$4,175,0002.69%
Redwood Investments, LLC 538,656$24,460,0001.97%
HighMark Wealth Management LLC 53,457$2,427,0001.78%
Taylor Wealth Management Partners 85,409$3,878,0001.37%
SILVERARC CAPITAL MANAGEMENT, LLC 66,673$3,028,0001.35%
Granite Investment Partners, LLC 919,029$41,733,0001.29%
View complete list of HALOZYME THERAPEUTICS INC shareholders